Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-09 | 2023-01-18 | 162271 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-06-09 | 2022-12-08 | 162274 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2022-06-09 | 2022-08-20 | 162277 |
TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162280 |
TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2022-06-09 | 2022-06-17 | 162283 |
TEVA-CAPTOPRIL | 12.5MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162286 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2022-06-09 | 2022-07-26 | 162291 |
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2022-06-09 | 2022-08-20 | 162297 |
TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162300 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-06-09 | 2022-11-12 | 162306 |
TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2022-06-09 | 2023-04-28 | 162309 |
AMPICILLIN SODIUM FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2022-06-16 | 2023-04-28 | 162846 |
TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2022-06-16 | 2022-09-23 | 162849 |
TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2022-06-16 | 2022-08-09 | 162852 |
TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2022-06-16 | 2023-07-06 | 162855 |
TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Resolved | 2022-06-16 | 2022-10-29 | 162858 |
TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-06-16 | 2022-09-08 | 162861 |
TEVA-QUININE | 300MG | CAPSULE | Resolved | 2022-06-16 | 2022-12-08 | 162864 |
TEVA-QUININE | 200MG | CAPSULE | Resolved | 2022-06-16 | 2022-12-08 | 162867 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT ZOPICLONE | 5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65191 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65213 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65218 |
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |
ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
ACT VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65305 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |